BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24700560)

  • 1. The Cd6 gene as a permissive locus for targeted transgenesis in the mouse.
    Ichise H; Ichise T; Sasanuma H; Yoshida N
    Genesis; 2014 May; 52(5):440-50. PubMed ID: 24700560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified RMCE-compatible Rosa26 locus for the expression of transgenes from exogenous promoters.
    Tchorz JS; Suply T; Ksiazek I; Giachino C; Cloëtta D; Danzer CP; Doll T; Isken A; Lemaistre M; Taylor V; Bettler B; Kinzel B; Mueller M
    PLoS One; 2012; 7(1):e30011. PubMed ID: 22253858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
    Dacquin R; Starbuck M; Schinke T; Karsenty G
    Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models for miRNA expression: the ROSA26 locus.
    Casola S
    Methods Mol Biol; 2010; 667():145-63. PubMed ID: 20827532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional transgene expression mediated by the mouse beta-actin locus.
    Jägle U; Gasser JA; Müller M; Kinzel B
    Genesis; 2007 Nov; 45(11):659-66. PubMed ID: 17987666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Z/AP, a double reporter for cre-mediated recombination.
    Lobe CG; Koop KE; Kreppner W; Lomeli H; Gertsenstein M; Nagy A
    Dev Biol; 1999 Apr; 208(2):281-92. PubMed ID: 10191045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted transgene insertion into the AAVS1 locus driven by baculoviral vector-mediated zinc finger nuclease expression in human-induced pluripotent stem cells.
    Tay FC; Tan WK; Goh SL; Ramachandra CJ; Lau CH; Zhu H; Chen C; Du S; Phang RZ; Shahbazi M; Fan W; Wang S
    J Gene Med; 2013 Oct; 15(10):384-95. PubMed ID: 24105820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stringent and reproducible tetracycline-regulated transgene expression by site-specific insertion at chromosomal loci with pre-characterised induction characteristics.
    Brough R; Papanastasiou AM; Porter AC
    BMC Mol Biol; 2007 May; 8():30. PubMed ID: 17493262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction.
    Belteki G; Haigh J; Kabacs N; Haigh K; Sison K; Costantini F; Whitsett J; Quaggin SE; Nagy A
    Nucleic Acids Res; 2005 Mar; 33(5):e51. PubMed ID: 15784609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
    Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M
    Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human CD7 transgenic mice.
    Schanberg LE; Lee DM; Fleenor DE; Ware RE; Patel DD; Haynes BF; Kaufman RE
    J Immunol; 1995 Sep; 155(5):2407-18. PubMed ID: 7544374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell-specific expression of Cre recombinase in transgenic mice.
    Li WL; Cheng X; Tan XH; Zhang JS; Sun YS; Chen L; Yang X
    Yi Chuan Xue Bao; 2005 Sep; 32(9):909-15. PubMed ID: 16201233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of pronuclear injection-based targeted transgenesis in mice through Cre-loxP site-specific recombination.
    Ohtsuka M
    Methods Mol Biol; 2014; 1194():3-19. PubMed ID: 25064095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice.
    Utomo AR; Nikitin AY; Lee WH
    Nat Biotechnol; 1999 Nov; 17(11):1091-6. PubMed ID: 10545915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An efficient system for tissue-specific overexpression of transgenes in podocytes in vivo.
    Moeller MJ; Soofi A; Sanden S; Floege J; Kriz W; Holzman LB
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F481-8. PubMed ID: 15784842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel reporter and deleter mouse strains generated using VCre/VloxP and SCre/SloxP systems, and their system specificity in mice.
    Yoshimura Y; Ida-Tanaka M; Hiramaki T; Goto M; Kamisako T; Eto T; Yagoto M; Kawai K; Takahashi T; Nakayama M; Ito M
    Transgenic Res; 2018 Apr; 27(2):193-201. PubMed ID: 29546522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.